ONWARD

05/08/2025

CORE (Center of Recovery & Exercise) is one of the activity-based training centers in the US to be equipped with our groundbreaking ARC-EX® System.

At CORE, people living with paralysis from neurological conditions can challenge their diagnoses thanks to state-of-the-art technology and neurorehabilitation techniques. Now, their Florida-based team is fully trained on using our ARC-EX Therapy to improve hand strength and sensation after a spinal cord injury.

Huge thanks to the team at CORE for your engagement during our training sessions, and for the critical work you’re doing to bring hope and a space for people to reach their potential.



To stay informed about our technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

22/07/2025

We are pleased to share the story about Walk The Line - Recovery Therapy, which is one of the first US clinics to use our ARC-EX® System to improve hand sensation and strength after a spinal cord injury.

Erica Coulston, President at Walk The Line, had this to say about her experience:

“It gives a glimmer of what could be, and that is so exciting. It makes you feel like you can do anything, and that is what we want.”

📺 Watch the Fox 2 Detroit segment here: https://www.fox2detroit.com/video/1675875



To be kept informed about the Company's technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

16/07/2025

📣 We'll be there! ONWARD is heading to the 2025 National Veterans Wheelchair Games, the largest annual wheelchair sports and rehabilitation event for US military veterans.

Held on July 17-22 in Minneapolis, Minnesota, the event is organized by U.S. Department of Veterans Affairs and Paralyzed Veterans of America. It’s an exceptional opportunity to celebrate strength, resilience, and athletic spirit. From basketball to pickleball, the games are open to US veterans with spinal cord injuries, amputations, multiple sclerosis, or other central neurological conditions requiring a wheelchair. 🏆

We’re proud to support this powerful platform and its mission to foster wider respect and opportunities for all people living with disabilities.

Heading to the games? Come see us at booth #526 to discover how our groundbreaking ARC-EX® System is helping shape the future of spinal cord injury.



To stay informed about our technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

11/06/2025

We're honored to be recognized as a company striving to make the world a better place on Fast Company’s 2025 World Changing Ideas list! 🌎💡

Fast Company World Changing Ideas Awards celebrate businesses and organizations developing creative solutions to the world's most pressing challenges. We’re thankful that our groundbreaking ARC-EX® System, the first and only FDA-cleared technology indicated to improve hand strength and sensation in people with chronic spinal cord injury, has been recognized for its potential to transform lives.

This honor belongs to our passionate team, dedicated partners, and everyone in the broader spinal cord injury community who inspire us daily. Together, we're demonstrating that pioneering medical technology can deliver life-changing impact for people with spinal cord injury and other movement disabilities.

Thank you, Fast Company, for shining a light on solutions that matter.

https://www.fastcompany.com/91336535/onward-medical-world-changing-ideas-2025

ARC-EX temporarily attaches electrodes to the skin to stimulate sensory nerves in the spine. It’s a winner in Fast Company’s 2025 World Changing Ideas Awards.

06/06/2025

Next Steps of O'Connor Foundation is one of the first spinal cord injury rehabilitation centers in the US to be equipped with our groundbreaking ARC-EX® System – the first and only FDA approved technology indicated to improve hand strength and sensation after spinal cord injury.

The launch of the ARC-EX System was a pivotal moment in our mission to help people with spinal cord injury, demonstrating our ability to successfully translate scientific discovery into meaningful, real-world impact.

As we continue to pioneer therapies to restore movement, function and independence, hear from Mary Jones and her team about how our technology is helping make a difference in the lives of those in the community.



To stay informed about our technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

03/06/2025

We were honored that U.S. Senator Patty Murray came to UW Medicine last month to witness firsthand the impact of our groundbreaking ARC-EX® System, the first and only FDA-approved technology for non-invasive spinal cord stimulation.

Senator Murray, former Chair of the United States Senate Committee on Veterans’ Affairs, is a respected advocate for healthcare research and veterans' issues recognized by groups like Paralyzed Veterans of America. She spent time with Dr. Moritz and ARC-EX Therapy trial participant Jessie Owen to learn how our therapy helps improve hand strength and sensation in people living with .

Thank you for your powerful advocacy, Senator Murray!



To be kept informed about ONWARD’s technologies, research studies, and the availability of therapies in your area, please complete the form linked in the comments.

ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

21/05/2025

⚡BREAKTHROUGH: Two more individuals with spinal cord injuries have received our investigational ARC-BCI® Therapy, bringing the total number of successful implants to five.

The ARC-BCI System pairs ONWARD’s brain-computer interface (BCI) with our implanted spinal cord stimulation technology to create the ONWARD DigitalBridge™, a wireless connection between the brain and the body that enables thought-driven movement after paralysis. Our BCI uses AI to decode brain signals and translate intention into movement.

Both procedures were performed at CHUV / Centre hospitalier universitaire vaudois by Chief of Neurosurgery Dr. Jocelyne Bloch, as part of research supported by EIC - The European Innovation Council and the Christopher & Dana Reeve Foundation, in collaboration with Prof. Gregoire Courtine and .NeuroRestore, EPFL and CEA.

Each procedure advances our understanding and refines our approach, bringing us closer to our vision to make thought-driven movement a reality for people living with paralysis.

You can read more in the press release: https://lnkd.in/eF6utMVY



ARC-BCI® and ARC-IM® are investigational and not available for commercial use. To stay informed about ONWARD’s technologies, research studies, and future availability in your area, please complete the webform linked in the comments below.

16/05/2025

We are pleased to share a second video aired by Anderson Cooper and 60 Minutes – “60 Minutes Overtime” – which goes beyond our work with brain-computer interface technology and explores other ways we are working to help people with spinal cord injury and movement disabilities.

This extended piece highlights the range of challenges faced by people with , including blood pressure instability and other complications. It also explores the potential for our investigational therapies to help people with Parkinson’s disease.

📺 Watch the 60 Minutes Overtime segment here: https://www.youtube.com/watch?v=u36M9U1qQVc

We are committed to pioneering innovative therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities.



ARC-IM® and ARC-BCI® are investigational and not available for commercial use. To stay informed about ONWARD’s technologies, research studies, and future availability in your area, please complete the form linked in the comments.

13/05/2025

The wait is over: Our 60 Minutes segment is now live! 📺

We’re honored to have been featured on CBS 60 Minutes in a powerful story by Anderson Cooper that highlights the potential of ARC Therapy to restore function and independence in people with spinal cord injury and other movement disabilities.

During their visit, the 60 Minutes crew met with the teams at NeuroRestore and ONWARD, as well as several participants in clinical trials including Marta Carsteanu-Dombi.

The segment follows the journey of people using our investigational spinal cord stimulation system, which can also be paired with our cutting-edge brain-computer interface to form the ONWARD DigitalBridgeTM, developed through years of groundbreaking research by Dr. Jocelyne Bloch and Prof. Grégoire Courtine.

▶️ Watch the full story here: https://www.youtube.com/watch?v=K84Wmjte5k4

We are deeply grateful to the participants, researchers, caregivers, and partners who help drive this meaningful mission forward.



ARC-IM® and ARC-BCI® are investigational and not available for commercial use. To stay informed about ONWARD’s technologies, research studies, and future availability in your area, please complete the form linked in the comments.

An Ironman athlete, told she'd never walk again after an accident more than six years ago, is now part of an early clinical trial, in which skull and spine i...

12/05/2025

📣 We'll be there! ONWARD Medical is heading to RehabWeek 2025—one of the most influential global events in neurorehabilitation!

Join us in Chicago from May 12–16 at the Sheraton Grand Chicago Riverwalk to discover how our ARC-EX® System is helping shape the future of spinal cord injury recovery.

Stop by our tabletop exhibit in the Riverwalk AB area (Level 1) to meet our team! We'll be showcasing our ARC-EX demo, sharing exciting Up-LIFT Trial results, and discussing ONWARD's vision for recovery.

We're looking forward to connecting with you in Chicago!

To be kept informed about the Company's technologies, research studies, and the availability of therapies in your area, please complete the webform in the comments below.



ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

08/05/2025

Mark your calendars: ONWARD Medical will be featured on CBS 60 Minutes this Sunday! 📺

Don't miss this groundbreaking segment showcasing our innovative technology and potentially transformative therapy designed to restore thought-driven movement after spinal cord injury.

AndersonCooper and the 60 Minutes team travel to Switzerland to witness our investigational ARC-BCI® platform in action, made possible by the pioneering research of Dr. Jocelyne Bloch and Prof. Grégoire Courtine, and our strategic collaboration with CEA.

📅 US viewers: Tune in at 7 p.m. ET this Sunday.
🎥 Watch the teaser https://www.youtube.com/watch?v=6XQa4cCLMDk



ARC-IM® and ARC-BCI® are investigational and not available for commercial use. To stay informed about ONWARD’s technologies, research studies, and future availability in your area, please complete the webform linked in the comments below.

Next Sunday, 60 Minutes reports on promising technology in an early clinical trial that’s helping paralyzed patients with spinal cord injuries stand up and w...

01/05/2025

Thank you NBC Chicago and Regina Waldroup for shining a light on the life-changing potential of our ARC-EX System. 🙏

In Willow Springs, is helping people like Bari Rubenstein rediscover strength, sensation, and hope. After 14 years as a quadriplegic, Bari’s words say it all:

“It feels like someone turned on a button and forgot to turn it off.”

The ARC-EX System is now available in rehabilitation clinics across the US.

For the complete story, visit: https://www.nbcchicago.com/news/local/suburban-clinic-uses-new-device-that-gives-hope-to-people-with-spinal-cord-injuries/3728184/.

To be kept informed about the Company’s technologies, research studies, and the availability of therapies in your area, please complete the webform in the comments below.



ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

Other Investigational Products: All other ONWARD Medical devices and therapies including ARC-IM and ARC-BCI are investigational and not available for commercial use.